0001127602-19-021563.txt : 20190613 0001127602-19-021563.hdr.sgml : 20190613 20190613163342 ACCESSION NUMBER: 0001127602-19-021563 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190612 FILED AS OF DATE: 20190613 DATE AS OF CHANGE: 20190613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bolorforosh Said CENTRAL INDEX KEY: 0001741776 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 19896458 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-06-12 0000313143 HAEMONETICS CORP HAE 0001741776 Bolorforosh Said 400 WOOD ROAD BRAINTREE MA 02184 1 EVP, Chief Technology Officer Common Stock 2019-06-12 4 S 0 69 109.37 D 2141 D Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. This number includes unvested restricted stock units previously reported. /s/ Thomas V. Powers, attorney-in-fact for Dr. Bolorforosh 2019-06-13